Harmony Biosciences Holdings (HRMY) Shares Outstanding (Weighted Average) (2019 - 2026)

Harmony Biosciences Holdings has disclosed Shares Outstanding (Weighted Average) across 8 years of filings, most recently posting $57.8 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $57.8 million, up 0.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $57.8 million (up 0.89% YoY), and the FY2025 annual result was $57.5 million, up 1.07% from the prior year.
• Shares Outstanding (Weighted Average) came in at $57.8 million for Q1 2026 at Harmony Biosciences Holdings, up from $57.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $59.9 million in Q3 2023 to a low of $56.8 million in Q1 2024.
• The 5-year median for Shares Outstanding (Weighted Average) is $57.8 million (2026), against an average of $58.3 million.
• Across the five-year window, Shares Outstanding (Weighted Average) grew 3.73% in 2022 and slipped 5.12% in 2024, its largest moves.
• Harmony Biosciences Holdings' Shares Outstanding (Weighted Average) stood at $59.2 million in 2022, then climbed by 0.5% to $59.5 million in 2023, then declined by 4.35% to $56.9 million in 2024, then gained by 1.07% to $57.5 million in 2025, then grew by 0.57% to $57.8 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $57.8 million (Q1 2026), $57.5 million (Q4 2025), and $57.7 million (Q3 2025), per Business Quant data.